Market revenue in 2024 | USD 197.3 million |
Market revenue in 2030 | USD 381.6 million |
Growth rate | 11.6% (CAGR from 2025 to 2030) |
Largest segment | Exocrine |
Fastest growing segment | Endocrine |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Exocrine, Endocrine |
Key market players worldwide | Accuray Inc, AstraZeneca PLC ADR, Novartis AG ADR, Pfizer Inc., F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, Ipsen Pharma, Eli Lilly and Co, Siemens Healthineers AG ADR, Elekta AB ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pancreatic cancer treatment market will help companies and investors design strategic landscapes.
Exocrine was the largest segment with a revenue share of 88.39% in 2024. Horizon Databook has segmented the UK pancreatic cancer treatment market based on exocrine, endocrine covering the revenue growth of each sub-segment from 2018 to 2030.
The pancreatic cancer treatment market in the UK is witnessing steady growth due to the increasing number of cases and advancements in therapeutic approaches. According to WHO, in 2022, the UK reported 11,351 new cases of pancreatic cancer, with nearly 9,000 deaths.
Making it the fifth leading cause of cancer-related mortality. The survival rate remains low, with less than 10% of patients surviving for five years after diagnosis. Chemotherapy, particularly gemcitabine and FOLFIRINOX regimens.
Continues to be the most common treatment approach. However, there is a growing focus on personalized medicine, with more emphasis on clinical trials exploring targeted therapies and immunotherapies.
Horizon Databook provides a detailed overview of country-level data and insights on the UK pancreatic cancer treatment market , including forecasts for subscribers. This country databook contains high-level insights into UK pancreatic cancer treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account